Healthcare & Wellness
·
4 min read
Pathos AI Raises $237M Series E at $3B Valuation for Cancer Drug Discovery Platform
Pathos AI raised $237 million in Series E funding at a $3 billion valuation, using AI to match cancer patients to clinical trials and identify drug response patterns — one of the largest health AI raises of 2026.
1h ago